title: Bilateral occlusive retinal vasculitis in a patient with primary antiphospholipid antibody syndrome.
authors.forename: Kiran
authors.initials: K
authors.lastname: Turaka
authors.forename: J Shepard
authors.initials: JS
authors.lastname: Bryan
authors.forename: Henry M
authors.initials: HM
authors.lastname: Kwong
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Ziemianski
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000068258:Bevacizumab; D004359:Drug Therapy, Combination; D017984:Enoxaparin / Q000627:therapeutic use; D005260:Female; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D017075:Laser Coagulation; D008875:Middle Aged; D015356:Retinal Artery Occlusion / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D031300:Retinal Vasculitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014606:Uveitis, Anterior / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014792:Visual Acuity / Q000502:physiology; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D017984:Enoxaparin; D005938:Glucocorticoids; D000068258:Bevacizumab; D014859:Warfarin